Iteos Therapeutics Inc (ITOS)
Iteos Therapeutics Inc (ITOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -113,341 | -34,613 | -134,414 | -90,702 | -45,344 |
| Depreciation Amortization | 664 | -2,139 | -10,280 | 916 | 614 |
| Accounts receivable | -78 | -105 | -3,407 | -2,632 | -2,102 |
| Accounts payable and accrued liabilities | -2,900 | 5,029 | -2,446 | -4,180 | -218 |
| Other Working Capital | 27,983 | -4,689 | 18,635 | -29,763 | -31,395 |
| Other Operating Activity | 11,462 | 2,753 | 33,731 | 22,683 | 12,118 |
| Operating Cash Flow | $-76,210 | $-33,764 | $-98,181 | $-103,678 | $-66,327 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26 | -24 | -25 | N/A | N/A |
| PPE Investments | -384 | -101 | -1,633 | -1,481 | -1,387 |
| Purchase Of Investment | -89,991 | -60,344 | -520,801 | -440,596 | -245,073 |
| Sale Of Investment | 225,047 | 108,161 | 391,308 | 297,309 | 193,182 |
| Investing Cash Flow | $134,646 | $47,692 | $-131,151 | $-144,768 | $-53,278 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,525 | 32 | 122,718 | 122,444 | 122,398 |
| Other Financing Activity | 0 | 0 | -477 | -488 | 0 |
| Financing Cash Flow | $4,525 | $32 | $122,241 | $121,956 | $122,398 |
| Exchange Rate Effect | 2,748 | 459 | -1,930 | -908 | -2,843 |
| Beginning Cash Position | 142,430 | 142,430 | 251,451 | 251,451 | 251,451 |
| End Cash Position | 208,139 | 156,849 | 142,430 | 124,053 | 251,401 |
| Net Cash Flow | $65,709 | $14,419 | $-109,021 | $-127,398 | $-50 |
| Free Cash Flow | |||||
| Operating Cash Flow | -76,210 | -33,764 | -98,181 | -103,678 | -66,327 |
| Capital Expenditure | -384 | -101 | -1,633 | -1,481 | -1,387 |
| Free Cash Flow | -76,594 | -33,865 | -99,814 | -105,159 | -67,714 |